I just read that there is good news in the search for a treatment for Pulmonary Fibrosis. A large pharmaceutical company is acquiring a much smaller one- a company that is in the second phase of clinical trials for a drug which could prevent development of fibrosis.
It sounds like a genetic link was found a few years ago, where those lacking some kind of receptor, developed fibrosis when exposed to environmental triggers. The drug would block the development of fibrosis.
I'm a bit unclear what this drug would mean- is it for those who have had genetic testing and haven't developed the disease yet (but are prone to it)? Is it for those who have the disease, and it keeps it from spreading?
Whatever the answer to these questions, it sounds like good news. Read more here.
